期刊文献+

短期联合应用灰黄霉素、克霉唑和地塞米松对红色毛癣菌的影响 被引量:1

Combination antifungal activity of griseofulvin,clotrimazole and dexamethasone
下载PDF
导出
摘要 目的研究灰黄霉素、克霉唑及灰黄霉素、克霉唑与地塞米松组合成的联合药物对红色毛癣菌在体内、外活性影响。方法在体外分别应用灰黄霉素、地塞米松、克霉唑、灰黄霉素∶克霉唑∶地塞米松=5∶5∶1联合药物的不同药物浓度作用于红色毛癣菌,确立药物最小抑菌浓度(MIC)和联合药物的分数抑菌浓度(FIC);制作由红色毛癣菌引起皮肤癣的豚鼠动物模型,根据豚鼠用药部位分成四组,对豚鼠皮疹进行疗效的评估。结果体外实验联合药物的MIC小于单药的MIC,且联合药物起协同和次协同作用;体内实验中联合用药组对动物受损局部皮肤给药后,对红色毛癣菌所致皮损积分为(1.89±0.68),与对照组(3.33±0.69)比较,可明显减轻局部皮肤损伤病变程度,该药优于克霉唑组(2.33±0.69)、灰黄霉素组(2.11±0.58)。结论短期内灰黄霉素、克霉唑与地塞米松组合成的联合药物有较强的抗红色毛癣菌和抗炎作用,其抗菌活性强于单独药物的灰黄霉素和克霉唑。 Objective To study combination antifungal activity of griseofulvin, clotrimazole and dexamethasone. Method Different concentration of drugs, such as griseofulvin, clotrimazole, dexamethasone and the combination of griseofulvin, clotrimazole and dexamethasone (griseofulvin/clotrimazole/dexamethasone = 5: 5: 1 ) was used to determine their minimus inhibited concentration (MIC) on the Trichophyton rubrum in vitro , and the Fractional inhibitory concentration (FIC) was calculated. Guinea-pig animal model of dermatophytosis was divided into four groups. The therapeutic effect of guinea pig tinea corporis models was evaluated according to skin lesions and scurf. Results The MIC of concentration of drugs in vitro is smaller than the MIC of single drug,and the concentration of drugs made the hypo-cooperation function;The combination groups are used on guinea pig tinea eorporis models, to the Trichophyton rubrum cause of the skin damage integral are ( 1.89 ± 0.68 ), contrast with the antitheses groups ( 3.33± 0.69) , it can reduce the degree of skin damage obviously, this drug is better than clotrimazole groups ( 2.33 ± 0.69 ) and griseofulvin groups ( 2.11 ± 0.58 ). Conclusion The combination of griseofulvin, clotrimazole and dexamethasone show significant antifungal effect, which is better than single drug.
出处 《中国真菌学杂志》 2009年第1期20-23,共4页 Chinese Journal of Mycology
基金 广州医学院学生学术科技项目基金(20071025)
关键词 灰黄霉素 克霉唑 地塞米松 红色毛癣菌 抗真菌活性 联合应用 griseofulvin clotrimazole dexamethasone combination Trichophyton rubrum antifungal activity combined drug therapy
  • 相关文献

参考文献8

二级参考文献38

  • 1Stevens DA. Therapy for opportunistic fungal infectious: past,present and future[ J ]. Indian J Cancer, 1995,32 (1) : 1.
  • 2Powderly WG,Keath M, Anderson S, et al. Amphotericin B-resistant Cyptococcus neoformans in a patient with AIDS[J]. Infect Dis Clin Pract , 1990,1 : 314.
  • 3Louie A,Kaw P,Banerjee P, et al. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endoearditis and pyelonephritis [ J ]. Anti Agents Chem ,2001,45(2) :485.
  • 4Yamaguchi H. Molecular and biochemical mechanisms of drug resistance in fungi [ J ]. Nippon Ishinkin Gakkai Zasshi, 1999,40(4) : 199.
  • 5Kohli A,Smriti,Mukhopadhyay K, et al. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry[J]. Anti Agents Chem,2002,46(4): 1046.
  • 6Loftier J, Einsele H, Hebart H, et al. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains[J]. FEMS Microbiol Lett ,2000,185(1) :59.
  • 7Perea S, Lopez-Robit JL, Kirkpatrick WR, et al. Prevalence of molecular mechanimns of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from HIV-infected patients [ J ]. Anti Agents Chem. 2001.45 (10) : 2676.
  • 8Asai K, Tsuchimori N, Okonogi K, et al. Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450[J]. Anti Agents Chem, 1999,43(5) : 1163.
  • 9Edlind TD,Henry KW, Metera KA, et al. Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance[J]. Med Myco1, 2001, 39 ( 3 ) :299.
  • 10Sanglard D, Ischer F, Koymans L, et al. Amino acid substitutions in the cytochrome P-450 lanosterol 14α-demethylase(CYP51A1 )from azole-resistant Candida albicans clinical isohtes contribute to resistance to azole antifungal agents [ J ]. Anti Agents and Chemo ,1998,42(2) :241.

共引文献53

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部